HK1006468A1 - Novel compounds - Google Patents

Novel compounds

Info

Publication number
HK1006468A1
HK1006468A1 HK98105680A HK98105680A HK1006468A1 HK 1006468 A1 HK1006468 A1 HK 1006468A1 HK 98105680 A HK98105680 A HK 98105680A HK 98105680 A HK98105680 A HK 98105680A HK 1006468 A1 HK1006468 A1 HK 1006468A1
Authority
HK
Hong Kong
Prior art keywords
novel compounds
anchor
less
gpiii
gpii
Prior art date
Application number
HK98105680A
Other languages
English (en)
Inventor
Marc Massaer
Alex Bollen
Diane Gregoire
Michel Heinderyckx
Paul Jacobs
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of HK1006468A1 publication Critical patent/HK1006468A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Liquid Crystal (AREA)
  • Piezo-Electric Or Mechanical Vibrators, Or Delay Or Filter Circuits (AREA)
  • Electrically Driven Valve-Operating Means (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK98105680A 1989-06-27 1998-06-18 Novel compounds HK1006468A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US37177289A 1989-06-27 1989-06-27

Publications (1)

Publication Number Publication Date
HK1006468A1 true HK1006468A1 (en) 1999-02-26

Family

ID=23465352

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105680A HK1006468A1 (en) 1989-06-27 1998-06-18 Novel compounds

Country Status (15)

Country Link
EP (1) EP0405867B1 (ko)
JP (1) JPH0349694A (ko)
KR (1) KR0166585B1 (ko)
AT (1) ATE119939T1 (ko)
AU (1) AU625328B2 (ko)
CA (1) CA2019845A1 (ko)
CY (1) CY1933A (ko)
DE (1) DE69017769T2 (ko)
DK (1) DK0405867T3 (ko)
ES (1) ES2071770T3 (ko)
HK (1) HK1006468A1 (ko)
IE (1) IE66516B1 (ko)
NZ (1) NZ234222A (ko)
PT (1) PT94479B (ko)
ZA (1) ZA904915B (ko)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824319A (en) * 1990-10-04 1998-10-20 Research Corporation Technologies, Inc. Varicella-zoster virus antigen
ATE196163T1 (de) 1990-10-04 2000-09-15 Res Corp Technologies Inc Varicella-zoster virusantigen
AU687355B2 (en) * 1992-07-17 1998-02-26 Merck Sharp & Dohme Corp. Method for preventing zoster or alleviating varicella related post-herpetic neuralgia
GB9226768D0 (en) * 1992-12-23 1993-02-17 Smithkline Beecham Biolog Vaccines
US6652850B1 (en) 1993-09-13 2003-11-25 Aventis Pharmaceuticals Inc. Adeno-associated viral liposomes and their use in transfecting dendritic cells to stimulate specific immunity
US5834441A (en) * 1993-09-13 1998-11-10 Rhone-Poulenc Rorer Pharmaceuticals Inc. Adeno-associated viral (AAV) liposomes and methods related thereto
KR970006484A (ko) * 1995-07-27 1997-02-21 수두 바이러스의 당단백질을 대량발현시키는 동물세포주
US7112331B2 (en) 1996-02-09 2006-09-26 Smithkline Beecham Biologicals, S.A. Vaccines against varicella zoster virus gene 63 product
JP2002504080A (ja) * 1996-02-09 2002-02-05 スミスクライン ビーチャム バイオロジカルズ ソシエテ アノニム 水痘―帯状疱疹ウィルス遺伝子６３産物に対するワクチン
KR100434023B1 (ko) * 1996-02-29 2005-05-09 주식회사 엘지생명과학 수두바이러스의당단백질을대량발현시키는동물세포주
DE19757767A1 (de) 1997-12-23 1999-07-15 Dade Behring Marburg Gmbh Immunreaktive Bereiche des Glycoproteins gpII des Varicella-Zoster-Virus (VZV)
GB9901254D0 (en) * 1999-01-20 1999-03-10 Smithkline Beecham Biolog Vaccines
GB0504436D0 (en) * 2005-03-03 2005-04-06 Glaxosmithkline Biolog Sa Vaccine
GB201116248D0 (en) 2011-09-20 2011-11-02 Glaxosmithkline Biolog Sa Liposome production using isopropanol
WO2014043189A1 (en) 2012-09-14 2014-03-20 The Regents Of The University Of Colorado, A Body Corporate Conditionally replication deficient herpes viruses and use thereof in vaccines
CA3045952A1 (en) 2016-12-07 2018-06-14 Glaxosmithkline Biologicals Sa Novel process
GB201621686D0 (en) 2016-12-20 2017-02-01 Glaxosmithkline Biologicals Sa Novel methods for inducing an immune response
US20210187098A1 (en) 2017-04-28 2021-06-24 Glaxosmithkline Biologicals Sa Vaccination
WO2018219521A1 (en) 2017-05-30 2018-12-06 Glaxosmithkline Biologicals S.A. Methods for manufacturing an adjuvant
EP3717001A1 (en) 2017-12-01 2020-10-07 GlaxoSmithKline Biologicals S.A. Saponin purification
US20210283238A1 (en) 2018-08-07 2021-09-16 Glaxosmithkline Biologicals Sa Novel processes and vaccines
EP3886901A1 (en) 2018-11-29 2021-10-06 GlaxoSmithKline Biologicals S.A. Methods for manufacturing an adjuvant
JP2022535091A (ja) 2019-06-05 2022-08-04 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム サポニン精製
CN112142829B (zh) * 2019-06-28 2022-02-22 怡道生物科技(苏州)有限公司 水痘-带状疱疹病毒gE蛋白突变体及其表达方法
CN112142828B (zh) * 2019-06-28 2022-02-01 怡道生物科技(苏州)有限公司 一种gE基因及表达该基因的载体
CN115819616A (zh) * 2021-07-28 2023-03-21 江苏瑞科生物技术股份有限公司 一种基因重组vzv融合蛋白及其制备方法和应用
EP4169513A1 (en) 2021-10-19 2023-04-26 GlaxoSmithKline Biologicals S.A. Adjuvant composition comprising sting agonists
WO2024017827A1 (en) 2022-07-19 2024-01-25 Glaxosmithkline Biologicals Sa Continuous process for vaccine production

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE118353T1 (de) * 1984-04-06 1995-03-15 Chiron Corp Rekombinanter herpes simplex gb-gd impfstoff.
US4618578A (en) * 1984-07-17 1986-10-21 Chiron Corporation Expression of glycoprotein D of herpes simplex virus
US4769239A (en) * 1984-08-21 1988-09-06 Merck & Co., Inc. Vaccine against varicella-zoster virus
EP0211756A1 (en) * 1985-08-01 1987-02-25 Merck & Co. Inc. Assay for varicella-zoster virus (VZV) antibodies
US4686101A (en) * 1985-08-02 1987-08-11 Merck & Co., Inc. Vaccine against varicella-zoster virus
US4952674A (en) * 1986-05-02 1990-08-28 Merck & Co., Inc. Vaccine against varicella-zoster virus
WO1989000196A1 (en) * 1987-06-30 1989-01-12 The Upjohn Company Virus proteins having reduced o-linked glycosylation

Also Published As

Publication number Publication date
KR910001060A (ko) 1991-01-30
ZA904915B (en) 1991-06-26
DK0405867T3 (da) 1995-05-22
EP0405867A1 (en) 1991-01-02
JPH0349694A (ja) 1991-03-04
PT94479B (pt) 1997-05-28
NZ234222A (en) 1992-03-26
IE902297L (en) 1990-12-27
AU5779290A (en) 1991-01-03
IE902297A1 (en) 1991-01-16
ES2071770T3 (es) 1995-07-01
CA2019845A1 (en) 1990-12-27
CY1933A (en) 1990-06-22
PT94479A (pt) 1991-02-08
ATE119939T1 (de) 1995-04-15
EP0405867B1 (en) 1995-03-15
KR0166585B1 (ko) 1999-01-15
DE69017769D1 (de) 1995-04-20
IE66516B1 (en) 1996-01-10
DE69017769T2 (de) 1995-07-13
AU625328B2 (en) 1992-07-09

Similar Documents

Publication Publication Date Title
HK1006468A1 (en) Novel compounds
AU2618088A (en) Fowlpox virus promoters
IT1229845B (it) Procedimento per la preparazione di perfluoropolieteri perossidici.
DE69007691D1 (de) Verfahren zur Herstellung von Alkylaluminoxanen.
DE59409751D1 (de) Verfahren zur Herstellung von hydroxyphenylsubstituierten 1,3,5-Triazinen
GB2186169B (en) Molecular beam source
AU636892B2 (en) Halogen substituted diphenylsulfides DO NOT SEAL CASE MAY LAPSE
DE69011202D1 (de) Radio-opaker Klebstoff/radio-opake Dichtung zur Detektion von Lücken.
AU599161B2 (en) Heat resistant resin composition by suspension polymerization
AU6420390A (en) N-alkyl-p-quinonediimino triazine compounds
AU9121182A (en) Vorrichtung zur durchfuhrung von physiologischen uebungen mit aktiven und passiven bewegungen
IT9019723A0 (it) Procedimento per la modificazione di copolimeri di acrilato
IE902286L (en) Use of isoxazolin-3-one derivatives as antidepressants
DE68918055D1 (de) Verfahren zur Abtrennung von Phenol.
FI960526A0 (fi) Menetelmä kumeenihydroperoksin valmistamiseksi
GB8917059D0 (en) Avipox virus promoters
AU4545285A (en) Verfahren und vorrichtung zur reinigung von textilien, insbesondere von teppichen
DE59006193D1 (de) Verfahren zur Hestellung von 4-Methylentetrahydropyran.
IT1229510B (it) Procedimento per la preparazione di alfa bromoalcilfluoruri.
EP0431472A3 (en) Resin compositions for light control sheets, and light control sheets prepared from said compositions
EP0431974A3 (en) Light beam deflector
IT1243446B (it) Procedimento di disturbo iff per elicotteri
ATE109124T1 (de) Verfahren zur enantiomerentrennung von benzopyranderivaten.
DE58906998D1 (de) Verfahren zur Herstellung von 4,5,6-Trichlorpyrimidin.
FI904321A0 (fi) Anordning foer omplacering och aoterplacering av en videosignal.

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)